BioHealth News Archive
We’re Open for Business! A First Sneak Peek of JLABS @ Washington, DC – Blog Post | JLABS (2)
Johnson & Johnson Innovation – JLABS @ Washington, DC: We did it! Persevering through a time of great challenge and change, today we’re happy…
Read More
Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson’s Disease & Related α-synucleopathies at the XXVI IAPRD World Congress
BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using…
Read More
Sound Off and Save the Date – Women Building Bio Virtual Conference on September 30, 2021!
Women Building Bio 2021 is just around the corner. Save the date for September 30th to join our 6th year of Women Building Bio.…
Read More
Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ – Washington Business Journal
On a first-quarter earnings call Thursday, Emergent's CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company. Image: https://www.bizjournals.com {iframe}https://www.bizjournals.com/washington/news/2021/04/29/emergent-biosolutions-to-submit-response-to-fda.html{/iframe}
Read More
Largest Bioscience Employers in Greater D.C. – Washington Business Journal
Locally Researched by: Carolyn M. Proctor, Washington Business Journal Apr 30, 2021, 6:00am EDT Source: The companies, Form 990s, SEC filings and regional economic…
Read More
Maryland’s biggest VC funding quarter in 20 years brought $560M to startups – Technical.ly Baltimore
Around Baltimore, folks tend to analyze economic trends through three vantage points: the city, the region and the state. No matter which level you’re…
Read More
How Novavax went from near collapse to potential Covid vaccine powerhouse – Washington Business Journal
A potential vaccine has brought new life to the embattled Gaithersburg biotech. Image: Novavax CEO Stanley Erck, left, and Gregory Glenn, head of research…
Read More
Vaccitech Announces Pricing of Initial Public Offering – Vaccitech
Oxford, UK – Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for…
Read More
Gain Therapeutics CEO Eric Richman Guests on BioTalk
Gain Therapeutics CEO Eric Richman joins BioTalk to Discuss His Career, Redefining Drug Discovery, and Ventures in the BioHealth Capital Region and Beyond. Listen…
Read More
The Immunology Capital Next to the Nation’s Capital in Maryland
This is a complimentary webinar - the optional attendee list is $39. For registration questions, please email Elizabeth Baker at liz.baker@bisnow.com What You'll Learn: …
Read More
George Mason University incoming executive André Marshall on innovation, tech workforce – Washington Business Journal
André Marshall will draw from his life experience across innovation and workforce development to drive Mason to new heights, he says. Image: Andre Marshall,…
Read More
Fighting Pandemic Fuels BioHealth Industry Growth in Montgomery County · BioBuzz
Montgomery County, Maryland, was a leader in biotechnology before COVID-19 hit, ranking among the highest in the nation for the number of life sciences…
Read More
Job Application for Managing Director, Baltimore at Techstars
Are you a servant leader of leaders? Can you “GiveFirst” with no expectation of anything in return? Do you believe that collaboration drives innovation?…
Read More
Matan Kicks Off Next Phase of Progress Labs™ with 532,000 SF of Spec Biomanufacturing and Research Space in Montgomery County, MD
Matan Companies announces today plans to transform its Milestone Business Park into a vibrant and collaborative life sciences destination known as Milestone Innovation Park.…
Read More
Novavax Vaccine Could Generate $33 Billion in Revenue through 2027, Analyst Says · BioBuzz
Novavax is aiming to seek Emergency Use Authorization for its COVID-19 vaccine NVX-CoV2373 later this spring. If the U.S. Food and Drug Administration gives…
Read More